Core Viewpoint - Fudan University's team has developed a groundbreaking "fiber chip" that integrates large-scale circuits within elastic polymer fibers, offering comparable information processing capabilities to traditional commercial chips while providing unique advantages such as flexibility and adaptability to complex deformations [1][2]. Group 1: Technological Breakthrough - The team has introduced the concept of "fiber devices" and has created over 30 new types of fiber devices with functionalities including power generation, energy storage, lighting, display, and biosensing, with some achieving preliminary industrial applications [1]. - The design of the "fiber chip" utilizes a multi-layer stacking architecture, moving beyond the traditional approach of only utilizing the fiber surface, and has developed a method compatible with existing chip manufacturing processes [2]. Group 2: Performance and Capabilities - The "fiber chip" achieves an integration density of 100,000 electronic components per centimeter, enabling efficient interconnection of transistors for digital and analog circuit operations [2]. - The architecture and manufacturing method of the "fiber chip" are versatile, allowing for the integration of organic electrochemical transistors capable of performing neural computation tasks [2]. Group 3: Application Potential - In the field of brain-machine interfaces, the fiber system is expected to provide new tools for brain science and the diagnosis and treatment of neurological diseases [3]. - The "fiber chip" enables the creation of soft, breathable electronic fabric systems that do not require external processors, enhancing the development of flexible electronic textiles [3]. - In virtual reality, smart tactile gloves based on the "fiber chip" can significantly improve user interaction experiences in scenarios such as remote surgery and virtual object interaction [3].

Group 1 - The core viewpoint of the article emphasizes the new guidelines issued by the National Development and Reform Commission and other ministries to strengthen the planning and direction of government investment funds [1] - The guidelines highlight that the focus of government investment funds will be on supporting the development of new productive forces, with key areas including emerging industries such as next-generation information technology, new energy, new materials, high-end equipment, new energy vehicles, green environmental protection, civil aviation, and marine engineering equipment [1] - Future industries identified in the guidelines include cutting-edge fields such as the metaverse, brain-computer interfaces, quantum information, humanoid robots, generative artificial intelligence, biomanufacturing, biological breeding, future displays, future networks, and new energy storage [1] Group 2 - The management measures propose that funds with top evaluation results will receive incentives such as public commendation, demonstration promotion, project recommendations, and resource guarantees [1] - National-level funds are encouraged to increase cooperation with local funds that rank high in evaluation results in terms of capital contribution and project investment [1] - Development and reform departments at all levels will provide lists of key government investment projects and quality private investment projects to funds with top evaluation results, guiding financial institutions to increase matching financing and reduce financing costs [1]

"江苏人口老龄化进程早、程度深，面临的压力与挑战也更为突出。"王明强表示，当前江苏正全力打造具有苏式特色的"苏适养老"品牌，推动养老服务体 系高质量发展。而他所在的南京中医药大学也依托自身学科优势，率先在全国提出"中医养老学"交叉学科，目前重点聚焦三大领域：一是中医药养老理论 与文化研究；二是中医药抗衰老方法与机制研究；三是中医特色养老服务体系构建与实践研究。作为学科带头人，王明强对推动中医与养老深度融合充满 信心和期待，"中医药在慢性病调治、康复护理等方面具有独特优势，是中华民族的瑰宝。在养老领域中，我们应当把它利用好、发展好。要让中医药为 中国式养老插上腾飞的翅膀。" 养老服务事关千家万户福祉，关乎社会和谐稳定大局。江苏省政协委员、南京中医药大学养老服务与管理学院执行院长王明强一直以来奔走于学校和养老 机构之间，深入调研、倾听民声。为进一步提升养老服务效能，他建议，江苏应着力培育更多养老服务产业集群与创新主体，全力打造长三角民政科技产 业高地。 此外，他还提出，应充分利用江苏在长三角一体化中的区位优势，主动联合上海、浙江、安徽等地，共同搭建"长三角民政科技成果交易平台"，定期举办 创新成果对接活动，加速科 ...

Core Viewpoint - The acquisition of 100% equity in Shenzhen Huada Sanjian Qifa Technology Co., Ltd. and Hangzhou Huada Xufeng Technology Co., Ltd. by BGI Genomics is aimed at enhancing its technological capabilities in spatial omics and nanopore sequencing, positioning the company as a leader in the global life sciences sector with a comprehensive product matrix covering "long-read sequencing + spatial omics" [2][3]. Group 1: Acquisition Details - The total transaction price for the acquisition is approximately 366 million yuan [2]. - The acquisition allows BGI Genomics to integrate cutting-edge technologies, creating a unique competitive advantage by combining short-read (DNBSEQ), long-read (CycloneSEQ), and spatial omics technologies [2][3]. - The integration will enable BGI Genomics to offer a one-stop service from library construction, sequencing to data analysis, enhancing customer service capabilities and stickiness [2]. Group 2: Strategic Implications - The acquisition is strategically beneficial for BGI Genomics in emerging fields such as brain-computer interfaces, where spatial omics technology can provide precise navigation for implantable devices [3]. - The pricing strategy of acquiring companies at the incubation stage allows BGI Genomics to avoid potential valuation premiums associated with mature business commercialization [3]. - The assessed value of the acquired companies is 158 million yuan for Sanjian Qifa and 207.7 million yuan for Xufeng, with a favorable dynamic price-to-sales ratio around 3, compared to industry peers [3]. Group 3: Performance Commitments - The acquired companies have performance commitments, with Sanjian Qifa promising a cumulative net profit of no less than 50.1 million yuan from 2026 to 2028, and Xufeng committing to 82.8 million yuan from 2028 to 2030 [4]. - If performance targets are not met, BGI Genomics will receive cash compensation, with maximum amounts covering 223 million yuan and 264 million yuan respectively [4]. Group 4: Revenue and Cost Synergies - The acquisition is expected to add new revenue streams from spatial omics and nanopore sequencing, enhancing the overall revenue scale of BGI Genomics [4][5]. - The integration of supply chain procurement and shared R&D resources is anticipated to reduce operational costs and improve overall profitability [5]. - Market analysts believe this strategic move will significantly enhance BGI Genomics' long-term profitability and industry influence, opening up further growth opportunities in the global sequencing and life sciences market [5].

Core Viewpoint - The acquisition of 100% equity in Shenzhen Huada Sanjian Qifa Technology Co., Ltd. and Hangzhou Huada Xufeng Technology Co., Ltd. by the company for approximately 366 million yuan aims to integrate cutting-edge technologies into its operations, establishing a unique competitive advantage in the global life sciences sector [1][3]. Group 1: Acquisition Details - The total transaction price for the acquisition is approximately 366 million yuan [1]. - The acquisition will allow the company to incorporate spatial omics and nanopore sequencing technologies into its product offerings, making it the only global enterprise to cover the entire product matrix of "long-read sequencing + spatial omics" [3]. - The integration will enable the company to provide a one-stop service from library construction, sequencing to data analysis, enhancing customer service capabilities and stickiness [3][5]. Group 2: Strategic Value - The acquisition is strategically significant as it connects short-read (DNBSEQ), long-read (CycloneSEQ), and spatial omics technologies, creating a comprehensive technical chain that is difficult for competitors to replicate [3]. - The spatial omics technology can provide precise navigation for brain-machine interface technologies, laying a core foundation for breakthroughs in this field [3]. Group 3: Pricing and Valuation - The acquisition was made at a stage when the target companies are still in the business incubation phase, allowing for a valuation that reflects the actual asset value and avoids potential overvaluation during commercial maturity [4]. - The assessed value of the target companies is 158 million yuan for Sanjian Qifa and 207.7 million yuan for Xufeng, with a dynamic price-to-sales ratio around 3, significantly lower than industry peers [4]. - Performance commitments from the sellers include a cumulative net profit of no less than 50.1 million yuan for Sanjian Qifa from 2026 to 2028 and 82.8 million yuan for Xufeng from 2028 to 2030, with cash compensation mechanisms in place for unmet targets [4][5]. Group 4: Market Impact - The acquisition is expected to enhance the company's long-term profitability and industry influence, with potential for revenue synergies and commercial realization in cutting-edge sectors [7]. - The deal aligns with industry trends towards deep mergers and acquisitions, positioning the company competitively within the global life sciences and gene sequencing markets [7].

转自：微讯江苏 1月31日，省政府办公厅印发《关于加快创新生态建设扶持科创型企业茁壮成长的若干措施》，从健全科创型企业梯度培育体系、深化"双高协同"营造激 励创新良好生态、推进改革创新增强发展动力3个方面推出22条措施。 2月1日，记者从江苏省科技厅获悉，省政府刚刚出台22条措施，聚焦培育六类企业和建设"六型生态"，大力营造激励创新的热带雨林式生态。 有关企业培育的目标已经明确：到2027年，力争科技领军企业达50家左右、独角兽及潜在独角兽企业达300家左右、高新技术企业达6.7万家左右、国家入 库科技型中小企业达10万家左右。 "六型生态"包括研发生态、创业生态、创投生态和人才环境、开放环境、政务环境。 在建设"六型生态"的措施中，记者看到不少新提法。例如，实施"实验室+"行动，鼓励企业牵头建设全国（省）重点实验室和国家技术创新中心、制造业 创新中心，构建"实验室+龙头（链主）企业+科创公司"协同体系。到2027年，年营业收入1亿元以上的高新技术企业实现研发机构基本覆盖。又如，设立 政策性科技保险条款清单，探索"算力入股"多元融资模式，推动金融资产投资公司（AIC）股权投资试点扩围等。 "青年"是诸多措施的 ...

Fixed Income - The report analyzes the new regulatory framework for insurance companies, highlighting five major changes aimed at improving asset-liability management [9][10] - The insurance industry's solvency indicators declined in Q3 2025, attributed to increased equity capital usage and dual pressure on liabilities [11] - Investment returns improved due to rising long-term bond yields and favorable A-share performance, reducing overall industry risk [12] - A selection of insurance subordinated bonds with specific criteria is recommended for investment, including those from major state-owned insurance companies [14] Pharmaceutical Industry - The pharmaceutical index fell by 3.31% recently, with a notable trend of Chinese innovative drugs expanding into international markets [15][17] - Companies like China Biopharmaceutical are enhancing their R&D capabilities through acquisitions and self-developed products, positioning themselves for potential overseas opportunities [18] - A focus on innovative drugs is recommended, with specific companies highlighted for their strong fundamentals and potential for stock price recovery [19] New Consumption - Ruoyu Chen and Wancheng Group are projected to see significant profit growth in 2025, driven by their proprietary brand business and operational efficiency improvements [21][23] - The government is promoting new service consumption growth points, aiming to enhance service supply and consumer experience [25][26] - The snack retail sector is evolving, with companies like Mingming Hen Mang rapidly expanding and innovating to meet consumer demands [24] North Exchange - The North Exchange indices saw over 6% growth in January 2026, indicating a market rebound and highlighting specific sectors for investment opportunities [28][29] - The overall market liquidity remains ample, with a focus on structural investment opportunities in specialized and innovative enterprises [29][30] Media - Alibaba's FY2026Q3 revenue is expected to reach 288.1 billion yuan, with cloud business growth anticipated despite a slowdown in e-commerce [32]

Quantum Technology - IonQ announced an $1.8 billion acquisition of SkyWater Technology to accelerate its roadmap towards fault-tolerant quantum computing, with plans to start functionality testing of 200,000 qubit QPUs by 2028 [6][8] - A Chinese research team discovered new principles in quantum systems using the 78-qubit superconducting quantum processor "Zhuangzi No. 2," which enhances the application of quantum computing in fields like financial modeling and drug development [7][9] Biomanufacturing - Kangnuo Biopharmaceutical submitted an application for listing on the Hong Kong Stock Exchange, focusing on mitochondrial medicine and NAD+ applications, with projected revenues of 303 million yuan in 2023 [10][11] - Guangdong Province released an action plan aiming for a 40% self-sufficiency rate in core strains of biomanufacturing by 2027, with a total output value exceeding 500 billion yuan [11] Hydrogen Energy and Nuclear Fusion - Sichuan Fusion New Energy Industry Investment Development Co., Ltd. officially commenced operations, supporting the construction of China's first internationally recognized fusion city [13] - CIMC Anrui announced the successful launch of China's first IV-type hydrogen gas bundle container, marking a significant advancement in domestic hydrogen storage and transportation technology [14] - Mingyang Electric and global leaders in hydrogen equipment established Guangdong Mingnuo Hydrogen Technology Co., focusing on high-end hydrogen equipment production [15] Brain-Computer Interface - Neuralink reported 21 participants in its human trials, with plans to enhance device performance by three times and introduce "blindsight" technology for the visually impaired by late 2026 [23][24] - The National Medical Products Administration in China is advancing the establishment of industry standards for brain-computer interface medical devices [28] Embodied Intelligence - Ant Group's Lingbo Technology open-sourced the LingBot-Depth model, significantly lowering development barriers in the industry and enhancing its competitive edge [31][32] 6G and Commercial Aerospace - CASIC successfully conducted a 120 Gbps laser communication experiment, doubling the previous rate and laying the groundwork for high-speed data transmission in commercial aerospace [33][34] - China plans to expand its "Space+" future industries, focusing on space infrastructure, resource development, and space tourism [36] Future Industry Catalysts - Key milestones for future industries in 2026 include significant events in quantum technology, biomanufacturing, hydrogen energy, brain-computer interfaces, embodied intelligence, and 6G [37][38]

Core Viewpoint - The acquisition of Shenzhen Huada Sanjian Qifa Technology Co., Ltd. and Hangzhou Huada Xifeng Technology Co., Ltd. by BGI Genomics is a strategic move to enhance its product offerings in the field of genomics, making it the only company globally to cover the entire chain of "long-read sequencing + spatial omics" technologies [1][2][3] Group 1: Acquisition Details - BGI Genomics announced a cash acquisition of 100% equity in both companies for approximately 366 million yuan [1] - The acquisition aims to integrate cutting-edge technologies, including Stereo-seq and CycloneSEQ, into BGI Genomics' existing product matrix [2][3] Group 2: Technological Integration - The integration of Stereo-seq and CycloneSEQ technologies will create a comprehensive technical chain that enhances BGI Genomics' competitive edge [2] - Stereo-seq technology is recognized for its international leadership in resolution and field of view, while CycloneSEQ offers unique advantages in long-read sequencing and real-time capabilities [3] Group 3: Strategic Positioning - This acquisition strengthens BGI Genomics' first-mover advantage in the AI medical field and brain-computer interface technology [4] - The company is positioned to lead in multiple cutting-edge sectors by leveraging its advanced technologies [4] Group 4: Financial Aspects - The acquisition is strategically timed to capitalize on the valuation window, allowing BGI Genomics to acquire assets at a more favorable price before they become commercially mature [5] - The estimated valuations for the acquired companies are significantly lower than comparable industry players, reducing financial pressure on BGI Genomics [5][6] Group 5: Risk Mitigation and Growth Potential - The acquisition includes performance guarantees from the sellers, providing a safety net for BGI Genomics and protecting shareholder interests [6] - The integration of new revenue streams from the acquired technologies is expected to enhance the company's overall revenue and profitability [6][7] Group 6: Industry Context - The acquisition aligns with the trend of deep mergers and acquisitions in the industry, reflecting a focus on strategic integration and value creation [7] - BGI Genomics' move serves as a model for similar industry consolidations, emphasizing the importance of building competitive barriers through comprehensive technology offerings [7]

Market Overview - The major indices showed mixed performance with the ChiNext Index up by 1.27%, the STAR Market 50 Index up by 0.12%, while the North Exchange 50 Index down by 0.29%, the Shenzhen Component Index down by 0.66%, and the Shanghai Composite Index down by 0.96% [1] - The TMT sector led the gains with SW Communication Cables and Accessories up by 6.11%, SW Communication Network Equipment and Devices up by 4.91%, and SW Film and Animation Production up by 2.16% [1] - Conversely, the TMT sector also saw declines with SW Horizontal General Software down by 2.68%, SW Vertical Application Software down by 2.37%, and SW Brand Consumer Electronics down by 2.15% [1] Domestic News - In the semiconductor materials and processes sector, Powerchip Semiconductor Manufacturing Corporation (PSMC) announced it will stop accepting orders by Q2 2026, focusing on core technologies like memory and power management [2] - Tianjin New Unisplendour's new computing architecture project has begun chip production, with expected annual shipments reaching thousands of chips and a projected sales scale of 500 million to 1 billion yuan by 2027 [2] - Yintai Technology plans to acquire 100% of Guanglong Integrated and Aojian Microelectronics to enhance its semiconductor industry chain and accelerate its IDM transformation [2] - Meixin Sheng's acquisition of Xinyan Microelectronics aims to enter the magnetic sensor field, enhancing its technology system for environmental perception and multi-modal sensing [2] Overseas News - STMicroelectronics reported a sales increase in Q4 due to rising demand for chips in personal electronics, communication devices, and industrial machinery, although automotive sector performance was below expectations [3] - Counterpoint Research forecasts Apple's Q4 2025 revenue to grow by 16% to $144 billion, driven by a strong iPhone upgrade cycle, with iPhone revenue up by 23% [3] - Texas Instruments expects significant growth in the data center market, with annual revenue projected at $1.5 billion, a 64% year-on-year increase, driven by cloud computing and AI server demand [3] - Kioxia and SanDisk extended their joint venture agreement for the Yokkaichi plant for five more years, committing to the development of 3D flash memory technology [3] AI Insights - Kunlun Wanwei launched the open-source SkyReels-V3, achieving advanced visual quality and instruction adherence in a unified multi-modal context learning framework [4] - Apple completed the acquisition of Israeli AI audio startup Q.ai, which specializes in detecting facial micro-movements for emotion and health monitoring [4] - Samsung confirmed the launch of next-generation AR glasses in 2026, integrating multi-dimensional interaction methods [4] - MiniMax released the Music2.5 music generation model, supporting various music styles and providing AI-assisted tools for music creation [4] Industry Tracking - The China Aerospace Science and Technology Corporation successfully tested a 240-ton reusable rocket engine, achieving international leading performance [5] - Yushut Technology released the open-source UnifoLM-VLA-0 model aimed at humanoid robot operations, enhancing physical interaction capabilities [5] - Gestalt Technology signed a strategic cooperation agreement with Fourier to advance brain-computer interface technologies [5] - Beidi New Materials' polymer film manufacturing project has achieved mass production, aligning with national new materials strategy [5] Earnings Forecast - Zhongke Feimeasure expects 2025 revenue between 1.95 billion to 2.15 billion yuan, a year-on-year growth of 41.27% to 55.75% [6] - Obi Optical anticipates 2025 revenue of 940 million yuan, a 66.53% increase, with a net profit of 123 million yuan [7] - Jiangfeng Electronics forecasts a net profit of 431 million to 511 million yuan for 2025, a year-on-year increase of 7.5% to 27.5% [7] - Xinyi Sheng expects a net profit between 9.4 billion to 9.9 billion yuan for 2025, a significant increase of 231.24% to 248.86% [7]